Denmark's Novo Nordisk offers $3.1 billion for Belgian biotech group Ablynx
Ablynx already rejected an offer by the Danish group on Dec. 14 and Novo Nordisk said the new bid, made on Dec. 22, was some 14 percent higher. The Belgian company was not immediately available for comment on Monday.
Danish drugmaker Novo Nordisk said it had made a 2.6 billion euros bid for Belgian biotech group Ablynx. Image source: Reuters